share_log

WAVE Life Sciences Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)

Benzinga ·  May 15 21:01

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on WAVE Life Sciences (NASDAQ:WVE) in the last three months.

The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings31100
Last 30D01000
1M Ago00000
2M Ago10000
3M Ago20100

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $13.4, along with a high estimate of $19.00 and a low estimate of $5.00. This current average reflects an increase of 14.82% from the previous average price target of $11.67.

price target chart

Deciphering Analyst Ratings: An In-Depth Analysis

A comprehensive examination of how financial experts...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment